Wedbush cuts Spyre Therapeutics price target to $120 from $123
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
12:48:32 PM UTC
SquawkNews
07:48 AM EST, 11/04/2026 (MT Newswires) -- Spyre Therapeutics (SYRE) has an average rating of buy an